BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Regulatory
Access Pharmaceuticals (ACCP) Receives 510(K) FDA Marketing Clearance For ProctiGard™ 7/22/2014
Vivione Biosciences Receives AOAC Certification, Positions Brand For Fast Growth In Food Industry 7/22/2014
Unique Pharmaceuticals, Ltd. Announces A Voluntary Nationwide Recall Of All Sterile Compounded Preparations Within Their Expiry Period Due To A Lack Of Sterility Assurance 7/21/2014
AltheaDx Laboratory Receives Accreditation From College of American Pathologists 7/21/2014
Novartis AG (NVS) Plant To Fall Under GlaxoSmithKline (GSK) Control 7/18/2014
Seres Health Makes Push For First Drug, And IPO, Of Microbiome Era 7/17/2014
Zynex (ZYXI.OB) Achieves Compound Pharmacy License Approval In 36 States 7/17/2014
U.S. Officials Fire 11 Scientists On Biosafety Panel In Midst Of Anthrax Crisis 7/16/2014
Repros Therapeutics Inc. (RPRX) Release: FDA Confirms Sperm And Testosterone Endpoints As Key Parameters For Assessment Of Androxal® Versus Approved Topical Gel And Placebo 7/16/2014
Federal Trade Commission Urged To Probe Shire, Sanofi (France) (SAN.PA) & Icahn Med School Over A "Conspiracy" 7/16/2014
AntiOp Release: FDA Designates Opioid Overdose Treatment For Fast Track Development Program 7/15/2014
Roche (RHHBY)'s Avastin Wins Priority Review For Cervical Cancer 7/15/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Finally Fesses Up To Adverse Events Data For Acthar 7/14/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces Continuation Of Iclusig Review Under The Article 20 Procedure In Europe 7/14/2014
QRxPharma Ltd. (QRXPY) Provides Feedback On End-of-Review Meeting With The FDA On Moxduo® 7/11/2014
HbA1c-direct™ From Carolina Liquid Chemistries Receives NGSP Certification 7/9/2014
GlaxoSmithKline (GSK) Has 30 Days To Clean Up Plant 7/8/2014
Aesica Meets New Serialization Requirements With A QAD ERP Upgrade 7/8/2014
Protein Sciences Corporation Receives Approval From FDA For 2014/15 Formulation Of Flublok® Influenza Vaccine 7/8/2014
Teva Pharmaceutical Industries Limited (TEVA) Tries Out A New Tactic In Battle For Generic MS Drug 7/7/2014
Beximco Pharmaceuticals Becomes First Bangladeshi Company To Receive GMP Approval From Taiwan Food and Drug Administration (TFDA) 7/7/2014
Recordati S.p.A : Carbaglu® Receives Orphan Drug Designation In The U.S. For Organic Acidemias 7/3/2014
Advaxis, Inc. Announces Filing For USDA Product License 7/2/2014
Aratana Therapeutics (PETX) Files For USDA Product License Of AT-014 Canine Osteosarcoma Immunotherapy 7/2/2014
Provista Diagnostics Laboratory Receives Accreditation From College of American Pathologists 6/26/2014
FDA Slaps GlaxoSmithKline (GSK) With Warning For Plant Quality Violations, Orders Company To Review Manufacturing Worldwide 6/26/2014
European Medicines Agency Release: Outcome Report On First European Collaboration Between Regulators And HTA Organisations 6/25/2014
Burzynski Research Institute Announces Lifting Of The FDA Partial Clinical Hold - Phase 3 Clinical Study Agreed Upon 6/24/2014
Cellectis (ALCLS)’ UCART19 Receives Advanced-Therapy Medicinal Product Classification From European Medicines Agency 6/23/2014
Centene Corporation's Kansas Subsidiary Awarded Accreditation From NCQA 6/18/2014
GrowBLOX Sciences, Inc. Secures Special Use Permit For Its Cultivation And Conversion Facility 6/18/2014
Harrisvaccines Becomes First In The Nation To Receive United States Department Of Agriculture (USDA) Conditional License For PEDv Vaccine 6/17/2014
US FDA Advisory Committee Recommends No Cardiovascular Outcomes Trial For Peripherally-Acting Mu-Opioid Receptor Antagonist (Pamora) Class Including Movantik 6/13/2014
AstraZeneca PLC (AZN) Release: FDA Adcom Recommends No CV Trial For PAMORA Class 6/13/2014
TxCell Granted Certificate Of GMP Compliance From ANSM For Cell Therapy Manufacturing Facility 6/12/2014
Sirion Biotech Release: Adenovirus Vectors Meet Critical FDA Requirement Regarding Risk Of Contamination With Infectious Agents 6/12/2014
European Medicines Agency Agrees Policy On Publication Of Clinical Trial Data With More User-Friendly Amendments 6/12/2014
Catalyst Clinical Resourcing, LLC Certified As A Woman Business Enterprise 6/10/2014
EffRx Receives U.S. Orphan Drug Designation For EX404 For Treatment Of Pediatric Polycystic Ovary Syndrome 6/10/2014
Europeans, U.S. Disagree Over Safety Of Ranbaxy Laboratories (RANBAXY.BO) Facility 6/6/2014
National Organization for Rare Disorders Urges FDA To Consider Rare Disease Treatment Implications When Setting Biologics Naming Policy 6/4/2014
PCI Given The Green Light In Anvisa Audit 6/4/2014
Sirona Biochem Announces Wanbang Biopharmaceuticals's Launch Of Pre-Clinical Validation 6/3/2014
IHMML Receives Conditional Zoning Approval From The Corporation Of Delta 6/2/2014
FDA Cites Manufacturing Concerns At Wockhardt (WOCKHARDT.BO)'s U.S. Unit 5/28/2014
Eisai Company, Ltd. (ESALY.PK)'s R&D Subsidiary Kan Research Institute Commences Full-Scale Operation at New Facility 5/26/2014
RXi Pharmaceuticals (RXII) Granted U.S. Notice Of Allowance Covering Self-Delivering (Sd-Rxrna) Technology Platform 5/22/2014
TxCell Release: Col-Treg Granted Advanced Therapy Medicinal Product (ATMP) Classification By The European Medicines Agency 5/22/2014
FDA Slams Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) For Continued Violations At Plant 5/22/2014
WuXi PharmaTech Co., Ltd. Toxicology Facility In Suzhou Passes OECD GLP Inspection 5/21/2014
CoreRx Expands Clinical Trial Supplies Manufacturing And Packaging 5/20/2014
Nordic Nanovector: Betalutin™ Granted Orphan-Drug Designation In The USA 5/20/2014
Medac Pharma, Inc. Announces Successful FDA Inspection Of Its Exclusive Methotrexate Manufacturer 5/15/2014
WuXi PharmaTech Co., Ltd. Facilities For Late- And Commercial-Stage Analytical And Stability Testing And Clinical-Trial Materials Manufacturing Pass FDA Audit 4/30/2014
Flamel Technologies (FLML) Announces Receipt Of Complete Response Letter From FDA Citing Issues At The Facility Of The Supplier Of The Active Ingredient 4/29/2014
Anaheim Clinical Trials (ACT) Clears Another FDA Inspection 4/29/2014
Pluristem Therapeutics (PSTI)'s Manufacturing Facility Approved By European Auditors For Phase 3 Trials 4/28/2014
Plandai Biotechnology, Inc. (PLPL.OB) Petitions South Africa Department Of Health For License To Conduct Cannabis Research 4/28/2014
Tolero Pharmaceuticals Receives FDA Orphan Drug Designation For Alvocidib For The Treatment Of Acute Myeloid Leukemia 4/23/2014
Salix Pharmaceuticals, Ltd. (SLXP) And Progenics Pharmaceuticals, Inc. (PGNX) Announce The Acceptance Of Submission To Expand The Use Of RELISTOR In Chronic Non-Cancer Pain By European Medicines Agency 4/22/2014
Vivione Biosciences Receives Coveted Letter Of No Objection (LNO) Designation From U.S. Department Of Agriculture Food Safety & Inspection Services 4/22/2014
Coldstream Laboratories Inc. Completes Successful FDA Inspection 4/21/2014
Lonza Inc.'s Facility In Singapore Received Good Manufacturing Practice (GMP) Certification From The HSA 4/17/2014
High Tech Solution For Controlling The Dengue Mosquito Is Approved By CTNBio 4/11/2014
FDA Release: Avita Medical Grants An Investigational Device Exemption For Compassionate Use Of ReCell 4/10/2014
ECCRT, A SynteractHCR Company, Recognized As An Accredited Training Facility By TransCelerate BioPharma 4/8/2014
FDA Moving Slow To Add Drug Inspectors In China 4/8/2014
Nexcyon Achieves European Regulatory Decision 4/7/2014
ChemCon GmbH Successfully Passes Its Fourth FDA Inspection 4/3/2014
Clinovo Release: Hands-On Trainings To Convert Clinical Data To CDISC SDTM Standards With CDISC Express 4/1/2014
IntegenX Announces ISO 9001:2008 Certification 4/1/2014
Abaxis, Inc. (ABAX) Receives CLIA Waiver For Capillary Sampling For Cholesterol, HDL And Triglycerides 4/1/2014
FDA Staff Raises Questions About MannKind Corporation (MNKD) Diabetes Device 3/28/2014
AXIS Clinicals Announces Successful Completion Of 13th U.S. FDA Audit 3/27/2014
Claimspartner® Becomes Second CIS Service Based Offering To Attain SSAE 16 Compliance 3/20/2014
Aesica Successfully Completes The Validation Of Its High Capacity Manufacturing Facility At Queenborough, UK Site 3/14/2014
POLARIS Announces Illumina CSPro Certification For Sequencing 3/14/2014
Northwest Biotherapeutics (NWBO) Receives Authorization For New Cancer Therapy In Accordance With $4 Billion German Medical Act 3/12/2014
ISPE To Conduct Quality Metrics Pilot Program With FDA Participation 3/12/2014
Mettler-Toledo (MTD) Release: Shedding New Light On Compliance And Regulatory Challenges 3/7/2014
FDA Approves Pluristem Therapeutics (PSTI)'s Commercial Scale Cell Manufacturing Process 3/6/2014
Regulatory Affairs Professionals Society Release: 257 Earn Regulatory Affairs Certification in Autumn 2013 3/5/2014
Pharmaron LLC Earns CFDA GLP Certification For Toxicology Facility 3/4/2014
Basilea Pharmaceutica (BSLN.SW) Reports That Isavuconazole Receives Qualified Infectious Disease Product Designation From FDA For The Treatment Of Invasive Mucormycosis 2/27/2014
ChinaBio(R) LLC Release: China Implements 30-Day Review For "Simple" M&A Transactions 2/26/2014
BioNJ Targets Streamlined Therapeutic Development With Clinical Trials Master Service Agreement Template 2/25/2014
Neurosearch A/S (NEUR.CO) Announces The Danish Business Authority's Decision In The Accounting Control Matter 2/21/2014
SCYNEXIS, Inc. Receives Qualified Infectious Disease Product (QIDP) Designation From The FDA For Antifungal Agent SCY-078 For Oral Use 2/21/2014
Intertek Microbiology Laboratory Achieves Bio-Safety Level 2 2/21/2014
Pluristem Therapeutics (PSTI) Submits FDA Orphan Drug Application For Preeclampsia 2/20/2014
Guerbet (GBT) Receives FDA Approval For A New Manufacturing Plant For Lipiodol® (Ethiodized Oil) Injection 2/20/2014
Selvita Received A GMP Certificate 2/18/2014
Shire plc's Massachusetts Facility Wins FDA OK To Manufacture Gaucher Disease Drug 2/14/2014
Pfizer Inc. (PFE) Statement On Today’s Joint Meeting Of FDA Advisory Committees 2/12/2014
TNI BioTech Announces SEC Clearance Of Form 10 Registration Statement And Clears Way To Upgrade To A Higher Exchange 2/12/2014
GMP Certification Boost For Cobra Biologics Ltd. 2/11/2014
Rho Offers Insight On Key Components Of New Drug Application Submissions 2/6/2014
BIOCOM Applauds Passage Of Farm Bill 2/5/2014
NextPharma Completes Successful U.S. FDA Inspection With No Observations 2/3/2014
Regulatory Affairs Professionals Society Updates The Essential Reference On Canadian Regulatory Affairs 1/30/2014
Ranbaxy Laboratories (RANBAXY.BO) Workers Fudged Test Results: FDA 1/28/2014
Victrex Obtains ISO Certification For Environmental Management System 1/28/2014
Aratana Therapeutics (PETX) Announces Conditional Approval Of Second Canine-Specific Antibody Therapy 1/28/2014
Corden Pharma Colorado Receives Potent Compound Safety Certification Approval From SafeBridge Consultants, Inc.® 1/27/2014
NextSource Biotechnology Announces FDA Short Supply Release Of The Formally Known Bristol-Myers Squibb Company (BMY) (CeeNu®) Brand Oncology Product Now Currently Marketed Under the NextSource Biotechnology Lomustine (CCNU) Exclusively In The U.S. 1/27/2014
Protalix Biotherapeutics, Inc. (PLX) Announces Successful Manufacturing Facility Evaluation By Health Canada 1/24/2014
Cantrell Drug Company Updates FDA Registration to 503B Outsourcing Facility 1/24/2014
Pluristem Therapeutics (PSTI)'s Cell Manufacturing Facility Marks Major Milestone With German Regulatory Approval Of New Scaled-Up 3D Manufacturing Process 1/23/2014
Suven Life Sciences Ltd's Pashamylaram's Unit Receives FDA Acceptance 1/22/2014
Regis Technologies, Inc. Reports Successful FDA Audit With No Form 483 Observations 1/21/2014
Fraunhofer IZI Granted Manufacturing Authorization For Second GMP Facility 1/21/2014
Exco InTouch Successfully Completes HIPAA Security Audit 1/20/2014
Bayer HealthCare (BAY) Commends AHS And CAPC For Updated Heartworm Guidelines 1/20/2014
ChinaBio(R) LLC Release: China Adds Regs To New IPO Process 1/17/2014
Vectura Group plc (VEC.L): Swedish Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/14/2014
Evidera Announces Release FDA Draft Guidance On Use Of The "EXACT" To Measure Symptoms Of COPD Exacerbations 1/14/2014
Smithers Pira Lansing Laboratory Achieves Key Accreditation For Medical Device And Pharmaceutical Product Testing 1/14/2014
Innovus Pharma Provides Regulatory And Commercial Update On The Label Indication For Zestra® For Female Sexual Desire Disorder ("FSDD") From Health Canada 1/10/2014
Cardeas Pharma Announces That FDA Grants QIDP Designation And Fast Track Review For The Company's Antibiotic Combination Product 1/8/2014
BASF Received Excipact™ Certification As Pharmaceutical Excipient Supplier 1/8/2014
Hospira, Inc. (HSP) In Hot Water As FDA Formally Slaps Indian Plant With Warning 12/27/2013
Two ISPE Studies Cited In FDA Statement to Congress 12/23/2013
TaiGen Biotechnology Receives Qualified Infectious Disease Product And Fast Track Designations From The FDA For Nemonoxacin (Taigexyn®) 12/23/2013
Daiichi Sankyo, Inc. (4568.t) To Help Ranbaxy Laboratories (RANBAXY.BO) Meet FDA Norms 12/19/2013
Caris Life Sciences Receives Tumor Profiling Industry's First ISO 15189 Medical Laboratory Accreditation 12/19/2013
Provectus Pharmaceuticals Inc. Type C Meeting With FDA Oncology Division Held December 16, 2013 12/18/2013
Cambrex Corporation (CBM) Manufacturing Facility Completes Successful FDA Inspection 12/17/2013
Cellceutix (CTIX) Submits Application For IRB Review To Commence Phase 2b Clinical Trial Of Novel Antibiotic Brilacidin 12/16/2013
INSYS Therapeutics Receives Subpoena From Office Of Inspector General 12/13/2013
Valent BioSciences Corporation Earns ISO 9001:2008 Re-certification Following A System-Wide Audit 12/12/2013
R-Biopharm Rhône Ltd Welcomes Scottish Government Moves To Improve Food Safety Standards 12/12/2013
NovaBay Pharmaceuticals, Inc. (NBY) Gains ISO 13485 Certification For The Design And Manufacturing Of Neutrophase® 12/11/2013
Easton Pharmaceuticals (OP: EAPH) Provides Update On Initiatives Towards Its Cancer Drug 12/11/2013
Biogen Idec, Inc. (Massachusetts) (BIIB) Plant That Makes Older MS Drugs Fails An FDA Inspection 12/10/2013
Reckitt Benckiser Pharmaceuticals Inc. Pharma Unit In The U.S. Is Raided By The Feds 12/9/2013
Frontage Laboratories Receives Approval For Manufacture Of Schedule I And Schedule II Drug Products 12/9/2013
China Agrees To Allow Ten Additional FDA Inspectors 12/9/2013
ARCA biopharma Announces IDE Submission To FDA For Gencaro Companion Diagnostic Test 12/5/2013
Wockhardt (WOCKHARDT.BO) Falls 4%, FDA Says Company Erased Key Trial Data 12/4/2013
FDA Approval For SCM Pharma Limited Following BTG plc (BTG.L)'s Drug Approval 12/3/2013
TxCell Obtains Manufacturing Accreditation Status For Its French Cell Therapy Manufacturing Facility 12/3/2013
ChemCon GmbH Receives Approval To Manufacture Semi-Solid Pharmaceuticals For Human Use 12/3/2013
Eisai Company, Ltd. (ESALY.PK) Submits Application For Proton Pump Inhibitor Pariet In Japan 11/28/2013
Unique Pharmaceuticals Applauds Passage Of Drug Quality And Security Act 11/27/2013
FDA Schedules Face To Face Meeting With Repros Therapeutics Inc. (RPRX) To Discuss Androxal® Efficacy 11/25/2013
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: CHMP Determines Dimethyl Fumarate In TECFIDERA® To Be A New Active Substance In The European Union 11/22/2013
Cytori Therapeutics, Inc. (CYTX) Comments On New Legislation For Regenerative Medicine In Japan 11/21/2013
Gentium S.p.A. Receives European Medicines Agency Orphan Drug Designation For Defibrotide For The Prevention Of GvHD 11/19/2013
Amgen (AMGN) and Sanofi (France) (SAN.PA) Drugs Can Reach U.S. Without Long Studies 11/15/2013
Investors Can Sleep Soundly As FDA Panel Backs Vanda Pharmaceuticals, Inc. (VNDA)'s Drug For The Blind 11/15/2013
Mylan Inc. (MYL) Applauds New Federal Legislation To Increase Anaphylaxis Preparedness In Schools 11/14/2013
Remediation To Continue Through 2014 At Hospira, Inc. (HSP)'s Rocky Mount 11/11/2013
Drug Regulator Asks Sun Pharmaceutical Industries Ltd to Halt Clinical Research at Mumbai Laboratory 11/11/2013
NanoViricides, Inc. (NNVC.PK) Announces that DengueCide™ Has Received Orphan Drug Designation From the European Medicines Agency 11/11/2013
Specialised Therapeutics Australia Receives Therapeutic Goods Administration Approval for Brain Tumour Visualisation Drug - Gliolan® 11/11/2013
FDA Slaps Aegerion Pharmaceuticals, Inc. (AEGR) CEO For "Serious" Violations Of Drug Promotion Law Following CNBC Interview 11/11/2013
Put Down That Doughnut: FDA Takes on Trans Fats 11/8/2013
Pharmagen Announces FDA Registration 11/6/2013
Cynosure, Inc. (CYNO) Receives Australian Regulatory Approval to Market PicoSure™, the First Picosecond Laser to Remove Tattoos and Benign Pigmented Lesions 11/6/2013
ACGT, Inc. Accredited by the Clinical Laboratory Improvement Amendments (CLIA) Program 11/5/2013
ISPE Named as a Source in FDA Strategic Plan for Preventing and Mitigating Drug Shortages 11/1/2013
Bio-Matrix Scientific Group Inc. (BMSN.OB)' Regen BioPharma Retains Cook General Biotechnology for Contract Manufacturing of HemaXellerate I 10/31/2013
Eisai Company, Ltd. (ESALY.PK) Submits Application To Expand Indication Of Anti-Alzheimer's Agent Aricept® As Treatment For Dementia With Lewy Bodies In Japan 10/31/2013
Specialty Pharmaceutical Formulation Developer Integral Biosystems, LLC Gets USPTO Trademark Approval for Integral's OcuSurf™ Product 10/28/2013
Mesoblast Limited (MSB.AX) Updates Market on Registration Plans for GVHD Cell Product in Japan 10/28/2013
Bridging Studies – What You Need to Know 10/24/2013
Cambridge Major Laboratories Europe, B.V. Announces Successful Cambridge Major Laboratories, Inc. Inspection at Weert Facility 10/22/2013
UK Regulator to Withdraw Approval for Wockhardt (WPL)'s Daman Plant 10/22/2013
Novasep's European Custom Manufacturing Passes FDA Inspection 10/22/2013
Cambridge Major Laboratories, Inc. Announces Successful FDA Inspection At Weert Facility 10/21/2013
Eppendorf AG Announces It Has Received Connecticut State Approval to Conduct Biosafety Level 2 Infectious Disease Related Research 10/21/2013
WuXi PharmaTech Co., Ltd. Receives CLIA Certification for Its Genomics Clinical Laboratory 10/17/2013
CMC Biologics Achieves Authorization for cGMP Commercial Manufacturing by the Danish Medicines Agency 10/15/2013
Wockhardt (WPL) Falls After U.K. Regulator Action on Factory 10/14/2013
Biotechnology Industry Organization (BIO) Disappointed Governor Brown Vetoed Patient Access to Biosimilars Bill 10/14/2013
Comprehensive Portfolio Prepared by The Alliance for Regenerative Medicine (ARM) Guides Companies Through Reimbursement Process 10/14/2013
Ranbaxy Laboratories (RANBAXY.BO) Jumps as US Plant Wins FDA Clearance 10/11/2013
Fujifilm Diosynth Biotechnologies' UK Site Receives Renewed Medicines and Healthcare Products Regulatory Agency Manufacturing Licence 10/9/2013
Easton Pharmaceuticals (OP: EAPH) Announces Application to Obtain a Distributorship License Towards Its Canadian Medical Marijuana Initiatives 10/4/2013
The Jackson Laboratory Genomic Medicine Obtains State of Connecticut Clinical Laboratory Licensure and CLIA Certificate of Registration 10/2/2013
Grassley Probes Two Drugmakers Over 340B Pricing Program 9/27/2013
DermTech International Initiates Commercial Testing and Validation of Assay in New Laboratory Facilities 9/25/2013
Oxygen Biotherapeutics, Inc. (OXBO) Submits to FDA Results of Requested Nonclinical Studies 9/23/2013
Achaogen Announces Agreement With FDA on a Special Protocol Assessment for a Phase 3 Clinical Trial of Plazomicin to Treat Infections Caused by Carbapenem-Resistant Enterobacteriaceae (CRE) 9/23/2013
FDA Accuses USV of Fudging Data 9/23/2013
ImmunoGen, Inc. (IMGN) Announces Positive Regulatory Decisions for Roche (RHHBY)'s Kadcyla® in the European Union and Japan 9/20/2013
VIVUS, Inc. (VVUS) Updates European Filing Strategy for Qsiva 9/20/2013
AntiOp, Inc. Release: Naloxone Nasal Spray on Development Fast Track as Emergency Treatment for Opioid Overdose 9/20/2013
PCI Synthesis Announces Successful FDA Inspection and Pre-Approval of Two Products 9/19/2013
Failure by Drugmakers, Researchers to Publish Clinical Trial Results Risk Patient Safety: UK Lawmakers 9/17/2013
Medivir AB (MVIRb.F): The Regulatory Process in Japan for Simeprevir 9/17/2013
Forest Laboratories, Inc. (FRX)'s Ceftazidime/avibactam Combination Receives Qualified Infectious Disease Product (QIDP) Designation From FDA 9/13/2013
GlycoMimetics, Inc. Announces European Medicines Agency’s Granting of Orphan Drug Status in European Union for GMI-1070 in Sickle Cell Disease 9/13/2013
BioIndustry Association Flagship UK Bioscience Forum is Now CPD-Certified 9/12/2013
RayBiotech Awarded ISO 13485 Certification 9/12/2013
NicOx SA (COX.PA) Receives Positive Opinion for European Orphan Drug Designation for Naproxcinod for the Treatment of Duchenne Muscular Dystrophy 9/11/2013
Aegerion Pharmaceuticals, Inc. (AEGR)' Lomitapide Receives Orphan Drug Designation in Japan for the Treatment of Homozygous Familial Hypercholesterolemia 9/9/2013
TG Therapeutics, Inc. (MHA)' Ublituximab (TG-1101) Receives Orphan Drug Designation for the Treatment of Nodal Marginal Zone Lymphoma and Extranodal Marginal Zone Lymphoma (Mucosa-Associated Lymphatic Tissue, MALT) 9/9/2013
CEL-SCI (CVM)'s Manufacturing and Laboratory Operations Deemed Compliant With GMP Requirements Following Audit by European Union Qualified Person for a Second Time 9/9/2013